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 Abstract 
Background. General Practitioners (GPs) play a key-role in the care of somatic and psychiatric problems in People 
With Schizophrenia (PWS). It is probable that, like other health professionals, GPs are not all free of prejudices towards 
PWS. In clinical practice, GPs sometimes interact with clients diagnosed with schizophrenia by specialists, passively 
accepting this diagnosis. Other times, GPs interact with clients having symptoms of schizophrenia but who have not 
been diagnosed. In this case, GPs are expected to actively make a diagnosis. Giving the key-role of GPs in the process 
of care, it is worthwhile examining whether passive acceptance and active usage of the diagnosis schizophrenia have 
differential effects on GPs’ attitudes toward people with this disorder.  
Aims. To investigate GPs’ views of schizophrenia and whether they were influenced by a “schizophrenia” label, 
passively accepted or actively used.  
Methods. Four-hundred and thirty randomly selected GPs were invited to complete a questionnaire about their views of 
schizophrenia, either after reading a description of this disorder and making a diagnosis, or without being provided with 
a description but passively accepting  the label “schizophrenia” given in the questionnaire.  
Results. The GPs who passively accepted the label schizophrenia (N=195) and those who actively identified 
schizophrenia from the description (N=127) had similar views. Compared to the GPs who did not identify 
schizophrenia in the description (N=65), those who used the diagnosis, actively or passively: more frequently reported 
heredity and less frequently psychosocial factors as causes of the disorder; were more sceptical about recovery; were 
more convinced of the need for long-term pharmacotherapies, believed more strongly that PWS should be discriminated 
against when in medical hospital; and perceived PWS as more dangerous and as kept at greater social distance. 
Conclusions. The diagnosis “schizophrenia”, however used, is associated with pessimistic views. Stigma education 
should be provided to GPs. 
 
 
 Effects of the diagnostic label “schizophrenia”, actively used or passively accepted, on general practitioners’ 




People diagnosed With Schizophrenia (PWS) have an average life expectancy nearly 25 years shorter that the 
general population (Saha, Chant, & McGrath, 2007), including higher risks of morbidity (Leucht, Burkard, Henderson, 
Maj, & Sartorius, 2007) and mortality for physical diseases (Capasso,  Lineberry, Bostwick, Decker, & Sauver, 2008). 
Lifetime prevalence of cardiovascular and metabolic diseases is higher in PWS than in the general population 
(Vancampfort et al., 2015), and mortality for cancer is 50% higher (Howard et al., 2010). It has been found that half of 
PWS have undiagnosed medical illnesses (De Hert et al., 2011), especially cardiovascular and pulmonary diseases 
(Laursen, Munk-Olsen, & Gasse,  2011). They also receive fewer general medical checkups, blood pressure and 
cholesterol checks than other patient groups (Roberts, Roalfe, Wilson, & Lester, 2007). 
Suboptimal health care for PWS may be related to some physicians’ limited knowledge of this disorder, and/or 
negative attitudes towards people with severe mental health problems (Solar, 2002; Liggins & Hatcher, 2005; Ucok et 
al., 2006; Corrigan et al., 2014; Henderson et al., 2014). Studies have revealed that physicians sometimes do not take 
the medical needs of PWS seriously, and that they tend to associate patient’s physical complaints with mental illness 
(Shefer, Henderson, Howard, Murray,  & Thornicroft, 2014) and to underestimate medical symptom severity 
(Thornicroft, Rose,  & Kassam, 2007). It has been also reported that when people with mental health problems are in 
hospital for physical health problems, some staff sometimes treat them with disrespect, keep them apart from the other 
patients, and transfer them to a psychiatric unit as soon as possible (Liggins & Hatcher,  2005; Thornicroft et al., 2009; 
Harangozo et al., 2014). Studies have also found that health care providers with stigmatizing attitudes about people with 
mental health problems are likely to be more skeptical about adherence to treatment, and less likely to refer PWS to a 
physical specialist when appropriate (Corrigan et al., 2014; Reavley, Mackinnon, Morgan, & Jorm, 2014; Sullivan et 
al., 2015; Mittal et al., 2016).  The promotion of a biogenetic model of schizophrenia in health contexts (Ahn, Proctor, 
& Flanagan, 2009) and in relation to the general population (Kvaale, Gottdiener, & Haslam, 2013) appears to have 
strengthened the view of schizophrenia as a chronic illness requiring control by life-time pharmacological treatment 
(Phelan, Yang, & Cruz-Rojas, 2006), and the perception of PWS as dangerous, unpredictable, and unable to control 
their behavior (Kvaale et  al., 2013; Read, Haslam, & Magliano, 2013).  
General Practitioners (GPs) play a key role in the diagnosis and treatment of somatic and psychiatric problems 
in PWS (Simon et al., 2005), and in the provision of counseling and family advice (Carr et al., 2004). In some countries 
most PWS have regular contact with their GP and receive adequate level of care for their mental or somatic problems 
(Oud et al. 2010; Hetlevik,  Solheim,  & Gjesdal, 2015), while in other countries this is not the case (Roberts et al., 
2007; Irfan, Caldas de Almeida, Irfan, Raza, & Farooq, 2015). 
It is probable that, like other health professionals, GPs are not all free of stereotypes and prejudices toward 
PWS (Mittal et al., 2014; Sullivan et al., 2015). Studies examining GPs’ beliefs about people diagnosed with severe 
mental health problems reported that they tend to have low levels of sympathy toward people who self-harm (Goldney 
& Bottrill,  1980; Parker et al., 2001), believe that it is difficult to talk with mentally ill persons, and view them as 
dangerous and unpredictable (Parker et al., 2001; Adewuya &  Oguntade, 2007). For instance, of 106 GPs in Turkey 
(Ucok et al., 2006), 28% viewed PWS as dangerous, 46% as untrustworthy, and 23% did not believe that they could 
recover even if treated. Other studies revealed that GPs have more negative attitudes toward PWS than toward 
otherwise identical persons diagnosed as having depression (Lawrie et al., 1996; Jorm, Korten, Jacomb, Christensen, & 
Henderson, 1999). In particular, GPs seem to consider patients’ pain complaints to be psychological rather than physical 
in origin more frequently if presented by PWS than by persons with depression (Lam, Lam, Lam, & Ku, 2013) and  GPs 
are more pessimistic about prognosis in schizophrenia (Goldney & Bottrill, 1983).  
Studies also suggest that GPs’ views of PWS are negatively influenced by the diagnostic label “schizophrenia” 
(Buchanan & Bhugra, 1992; Lawrie et al., 1996; Mittal et al., 2014; Sullivan et al., 2015). Studies about the effect of the 
diagnosis “schizophrenia” on health professionals’ attitudes toward people with this disorder often use case vignettes 
with or without the diagnostic label. When two samples of London GPs (Lawrie et al., 1998) were sent a case vignette 
of an identical person, those whose vignette was labeled as “schizophrenia” were more likely to think that they would 
be violent, and less willing to have them on their practice list. However, this design does not allow differentiation 
between the effect of passively being presented with the label and the effect of actively diagnosing someone(Morgan, 
Reavley,  & Jorm,  2014; Sullivan et al., 2015; Imhoff, 2016). Other studies compared attitudes towards PWS among 
medical students who identified schizophrenia in a clinical description vs. those who did not (Magliano et al., 2011). 
These studies found that labeling a case as schizophrenia was associated with pessimism about recovery and with 
perception of higher social distance from persons with this diagnosis. However, this design did not allow one to 
distinguish the effect of diagnostic competence (i.e., actively diagnosing someone as having “schizophrenia”) from that 
of the label “schizophrenia” per se on respondents’ attitudes. 
In clinical practice, GPs sometimes interact with clients diagnosed as having schizophrenia by specialists, 
passively accepting this diagnosis. Other times, GPs interact with clients having symptoms indicative of  to 
schizophrenia and not diagnosed yet. In this case, GPs may be asked to actively to make a diagnosis and provide the 
appropriate treatments. Giving the key-role of GPs in the process of care, it is worthwhile to examine whether passive 
acceptance and active usage of the diagnosis schizophrenia has differential effects on GPs’ attitudes toward people with 
this disorder.  
In this paper, we report the results of a study investigating views of schizophrenia in a randomly selected 
sample of registered GPs in Italy. We examined whether GPs’ views varied in relation to GPs’ active usage or passive 
acceptance of the diagnostic label “schizophrenia”.  To our knowledge, this is the first study exploring GPs’ views of 
schizophrenia in relation to this active-passive dichotomy. We also re-examined previous findings that the label is 
related to negative attitudes, by comparing scores between those who employed the label (actively or passively) with 
those who did not apply the diagnosis when presented with a clinical  description of this disorder. 
The views measured were about:  
a) Causal beliefs 
b) Possibility of recovery  
c) Usefulness of psychological treatments  
d) Usefulness of pharmacological treatments 
e) Need of long-term pharmacological treatments 
f) Reliability of  PWS in reporting health problems to clinicians 
g) Insight of PWS into their own condition 
h) Discriminatory treatments of PWS in non-psychiatric hospital wards 
i) Perception of dangerousness of PWS 
j) Perception of social distance from PWS  
k) Perceived PWS’ difficulties in romantic relationships 
We hypothesized that GPs who expressed their views of schizophrenia after identifying this  disorder in a 
clinical description  (Active Schizophrenia Diagnosis - ASD) and GPs who expressed their views with reference to a 
pre-assigned diagnostic label “schizophrenia” and without being provided with a clinical description of this disorder 
(Passive Schizophrenia Diagnosis – PSD) would place more relevance on biogenetic factors and have more negative 
attitudes towards PWS than GPs who were not able to identify schizophrenia in the clinical description (Non 




Materials and Methods 
 
Study design 
The study was carried out on a randomly selected sample of 50% of the 860 registered GPs of the Naples 
central health district in the period June 2013 – March 2014. GPs were selected from the health district official GP lists, 
using SPSS random case selection command.  
To differentiate the effect of active usage and passive acceptance of the schizophrenia diagnostic label, 215 
GPs were randomly assigned to a group who was invited to read an undiagnosed ICD-10 clinical description of 
“schizophrenia” (reported in the Appendix), make a diagnosis and then complete the Opinions on mental illness 
Questionnaire (OQ) with reference to “people with a disorder like that reported in the description”. The remaining 215 
GPs were assigned to a group who was asked to complete the same questionnaire just in relation to ‘PWS’, i.e., in this 
group GPs were not provided with a clinical description, but the diagnosis “schizophrenia” was given in the 
questionnaire. Analyses compared views of GPs who actively made a diagnosis of schizophrenia after reading the 
clinical description of this disorder (Active Schizophrenia Diagnosis – ASD), GPs who did not do so for the same 
clinical description (No Schizophrenia Diagnosis - NSD), and GPs who responded to the pre-assigned diagnostic label 
schizophrenia, only (without being provided with a clinical description of this disorder; Passive Schizophrenia 
Diagnosis – PSD).  
Each GP was contacted personally or by phone by a researcher (A.S., R.P., or  R.A.) and asked for his/her 
informed consent to take part in the study. GPs who agreed to participate either completed the self-reported 
questionnaire in the presence of the researcher at the GP’s medical office or by mail, according to their preference. 
During completions of the OQ, the researcher was available to provide GPs with explanations about the content of 
items, upon request. No pressure was put on the respondents. Information on GPs’ demographic variables, professional 
background and experience with persons having the disorder were also collected.  
The study was approved by the Research Ethical Board of the Department of Psychology of the Campania 
University of Caserta, Italy (former denomination: Second University of Naples, Italy) and carried out in accordance 
with the Helsinki Declaration for experiments involving humans. 
 
Assessment instrument 
The OQ (Magliano, Fiorillo, De Rosa, Malangone, & Maj, 2004a) is a self-report tool exploring beliefs 
about the bio-psycho-social factors involved in the development of schizophrenia, and the treatments, prognosis 
and psychosocial consequences of this mental health problem. The tool, initially developed and validated in 
samples of relatives of PWS (Magliano et al., 1999), was subsequently modified and re-validated with 279 persons 
diagnosed with this disorder (Magliano et al., 2009). Recently, the instrument has been further modified to be 
applied in health contexts (Magliano et al., 2014), and by the inclusion of items selected on the basis of the 
research literatures (Varese et al., 2012). The most recent version of the tool included: a) 16 yes/no items exploring 
factors involved in the development of schizophrenia; b) 4 yes/no items about which professionals should be 
involved in the treatment of people with this disorder; c) 26 items on views about treatments, prognosis, and 
psychosocial consequences of the disorder, rated on a 3-point scale from 1= “not true” to 3= “completely true, and 
grouped as follows: 1) possibility of recovery; 2) usefulness of pharmacological treatments; 3) usefulness of 
psychological therapies; 4) need of long-term pharmacological therapies; 5) insight of PWS; 6) perception of 
social distance from PWS; 7) dangerousness; 8) treatments of PWS in non-psychiatric hospital wards; 9) reliability 
of PWS in reporting their health condition to medical doctors; 10) difficulties of PWS in having romantic 
relationships. 
 The psychometric properties of the above mentioned version of the OQ (section c) have been previously 
investigated in terms of content validity (Magliano et al., 2014; Magliano et al., 2016). In this study sample, the 
psychometric properties of OQ section c have been further examined in terms of content and construct validity, by 
means of Cronbach’s alpha coefficient and Confirmatory Factor Analysis (CFA) (see Statistical Analyses and 
Results sections, and Table 3). 
 
Statistical analyses 
Chi squares (χ2) were performed to compare the ASD, NSD and PSD groups in terms of factors involved 
in the development of schizophrenia (OQ section a), and views about which professionals should be involved in 
the care of PWS (OQ section b). Confirmatory Factor Analysis (CFA) was performed on OQ section c items to 
verify construct validity by applying maximum likelihood estimation of the covariances, in the LISREL 8 
Program, (Jöreskog & Sörbom, 1996). Cronbach’s alpha values were computed to explore the content validity of 
factors. Multivariate Analysis of Variance (MANOVA) was used to compare the mean scores of factors 1 to 10 
(OQ section c - dependent variables) among the three GP groups (ASD, NSD and PSD - independent variables). 
Post-hoc adjustment for multiple comparisons were performed by Bonferroni tests (ASD vs. NSD; ASD vs. PSD: 
NSD vs. PSD). The statistical significance level was set at p<0.05. Chi squares (χ2) and MANOVA were 





Descriptive results on the global sample 
Of the 430 contacted GPs, 43 (10%) declined to participate (reasons: not interested 62%, no time 12%, 
personal reasons 12%, unknown 14%), leaving a sample of 387 participants. The 387 GPs were mainly male (312, 
80.6%), and married (341, 88.6). Their mean age was 58.3 ± 5.2 years. The majority (373, 96.4%) had achieved a MD 
degree more than 20 years previously and had a post graduate medical training (283, 73.1%). Three-hundred and fifteen 
(81.4%) GPs stated they had patients with schizophrenia.  Of the 387 participants, 17 (4.4%) requested explanations 
from the researcher regarding the content of  items  (maximum of ten items), while 370 (95.6%) filled it out without 
asking any questions. 
One-hundred and ninety-five GPs completed the questionnaire in relation to just the given diagnostic label 
“schizophrenia” (PSD), and 192 filled in the questionnaire after reading the clinical description of schizophrenia and 
making a diagnosis. Of this latter group, 127 respondents (66.1%) diagnosed the clinical description as “schizophrenia” 
(ASD), and 65 (33.9%) did not (NSD). Of these 65, 49 (75.4%) diagnosed “depression” (alone or with anxiety and/or 
other mental illness and/or nervous breakdown), 11 (16.9%) reported “a mental illness”, 4 (6.1%) indicated “a nervous 
breakdown”, and 1 (1.5%) reported “don’t know”.  Of the 65 GPs who did not diagnose schizophrenia in the clinical 
description, 55 (84.6%) were male, 59 (90.8%) were married. Their mean age was 58.8 ± 4.7 years. The majority (64, 
98.5%) had achieved a MD degree more than 20 years previously and had a post graduate medical training (44, 67.7%). 
Fifty-nine (90.8%) GPs stated they had clients with a disorder like that reported in the description.  The 65 NSD GPs 
did not differ significantly from the ASD GPs in the  socio-demographic and professional background variables 
reported above, except for the percentages of GPs reporting to have patients with the disorder (76.4% vs. 90.8%, χ2= 
5.8, df 1,  p<0.02). 
In the total sample, the factors most frequently reported as involved in the development of schizophrenia were 
heredity (78.0%), use of street drugs (51.2%) and chemical imbalance (50.4%; Table 1). However, 81.4% of 
respondents endorsed at least one psychosocial factor among the causes of the mental health problem (most frequently 
psychological violence - 43.4%, and traumatic events - 38.2%). Ninety-three percent of GPs recommended the 
psychiatrist as an appropriate treating professional, and 48.6% recommended the psychologist. Moreover, 33.3% 
recommended the GP and 14.5% the neurologist. 
 In the total sample, 26.6% of GPs thought it was ‘completely true’ that PWS could recover, and 37.9% were 
equally sure that people with this problem should take drugs for life (Table 2). Thirty-eight percent of GPs were fully 
convinced that PWS are kept at distance by others, and 24.1% firmly believed that these persons are dangerous to 
others. Moreover, 28.3% of GPs firmly believed that people with this problem should be supervised in hospital wards. 
Confirmatory Factor Analysis performed on the 26 items initially included in OQ section c confirmed the 10-
group structure listed above, with the exclusion of three items. The details of the CFA are presented in Table 3. The 
final model fit the data well, with all factor loadings significant at the p < 0.001 level. Cronbach’s alpha values of 
section c factors, ranging from .66 to .84, are reported in Table 3. 
 
Differences in views of schizophrenia among ASD, PSD, and NSD groups 
The factors most frequently reported as involved in the development of schizophrenia differed by group. In 
particular, heredity, chemical imbalance and misuse of street drugs were the factors most frequently endorsed by both 
the ASD and the PSD groups, and stress, work difficulties and family conflicts were the factors most frequently 
endorsed by the NSD group (Table 1). The percentage of GPs who endorsed heredity was significantly higher in the 
ASD and in the PSD groups than in the NSD group (χ2= 61.66, df 2, p<.0001).  Compared to ASD and to PSD, a higher 
percentage of GPs in the NSD group endorsed the following psychosocial factors: stress (χ2= 45.23, df 2,  p<0.0001), 
family conflicts (χ2= 25.72, df 2,  p<0.0001), disillusionment in love (χ2= 24.50, df 2,  p<0.0001), work difficulties (χ2= 
46.66, df 2,  p<0.0001;), bereavements (χ2= 33.60, df 2,  p<0.0001), and physical illness (χ2= 21.92, df 2,  p<0.0001). 
 In each group, ‘psychiatrist’ was the profession most frequently recommended for treatment (range: 72.3% - 
97.6%), followed by ‘psychologist’ (44.6% - 64.6%), ‘GP’ (31.3%-43.1%), and ‘neurologist’ (11.8% -16.4%).  In the 
NSD group, a higher percentage of respondents did not recommend psychiatrist than in the ASD and in the PSD groups 
(27.7% vs. 2.4% vs. 3.1%, χ2= 51.7, df 2, p<0.0001). 
Multivariate analysis of variance, performed on OQ factors 1 to 10, revealed a significant effect of the groups 
on six of the factors (Table 4). Bonferroni post-hoc comparisons revealed that GPs in ASD and PSD groups did not 
significantly differ from each other in their views of schizophrenia. Bonferroni post-hoc analysis showed that GPs in the 
NSD group were more optimistic about the possibility of recovery compared to GPs in the ASD group and in the PSD 
group. Post-hoc analysis also revealed that GPs in the NSD group was less convinced of the usefulness of drug 
treatments and the need for long-term pharmacological treatments compared to GPs in the ASD and to those in PSD 
groups.  Finally, post-hoc analysis also showed that GPs in the NSD group had less restrictive views about how these 
persons should be treated in non-psychiatric hospital wards and perceived these persons as less dangerous, and as being 





Interpretation of the results  
The results of this study show that GPs that actively attribute the diagnosis of “schizophrenia” to a clinical 
description differ from those who make other, or no, diagnoses and are similar to those who respond to the label 
“schizophrenia” when already provided. These findings suggest that the diagnosis “schizophrenia” is associated with a 
biological and pessimistic view regardless of whether it is used actively (i.e., diagnostic competence) or is just passively 
accepted.  
 Although the majority of GPs emphasised biogenetic factors among the causes of schizophrenia, they are 
aware of the role of psychosocial factors in the development of this disorder, as indicated by 81.4% mentioning at least 
one non-biological cause. However, a large minority of GPs do not seem fully aware of the effectiveness of non-
pharmacological treatments (Mueser, Deavers,  Penn, & Cassisi, 2013). Only 57.3% were completely convinced that 
psychological interventions are useful in the treatment of schizophrenia, and only 48.6% recommended a psychologist. 
These results might be related to greater exposure of GPs to pharmacological education of the kind provided by 
pharmaceutical companies and a limited focus on more integrated bio-psychological care in medical curricula (Astin,  
Sierpina, Forys, & Clarridge, 2008) and Continuous Medical Education programs. 
In the ASD and PSD groups, GPs more frequently reported heredity among the causes, were more pessimistic 
about recovery, and were more convinced of the usefulness and need of long-term pharmacological treatments for 
schizophrenia. These results are in line with previous findings on the relationships between the diagnosis of 
schizophrenia and adoption of a biogenetic causal model (Read et al., 2013), and between labelling, biogenetic 
explanations and views of schizophrenia as an incurable illness, requiring pharmacological treatments with a focus on 
control and containment (Kvaale et al., 2013).  
In the total sample, only 26.6% of GPs were completely convinced that PWS could recover. The GPs’ pessimism 
about prognosis could be in part related to the ambiguous meaning of the term “recovery” (Ng, Pearson, Chen, & Law, 
2011). Some GPs may view it as implying being symptom-free and without need of further treatment, while others may 
take it to mean living a meaningful life, even with some symptom continuation and occasional support from mental 
health services (Bellack, 2006). However, this level of skepticism about the “possibility” of recovery, however it is 
defined, is of concern. It may negatively influence the information and hope that GPs convey to their clients, and it may 
discourage PWS themselves from making efforts to improve their lives.  
Compared to the NSD group, the ASD and PSD groups perceived PWS as more dangerous, as kept at higher 
social distance by others and as needing to be treated differently in non-psychiatric hospital wards. These results 
support previous findings on the toxic effect of the diagnostic label of “schizophrenia” on perceptions of dangerousness 
(Read et al., 2013). Some authors explain this association as consequent of viewing people with this mental health 
problem as incapable of controlling their aggressive behaviors, since these behaviors are due to chemical imbalance 
and/or by genetic dysfunctions (Kvaale et al., 2013).   
Regarding the 65 GPs that did not identify “schizophrenia” from the clinical description (NSD), it is possible 
that these GPs lack knowledge about schizophrenia or mental health issues in general. It should also be considered that 
in the NSD group, 75.4% of GPs diagnosed depression. Therefore, it cannot be excluded that the relevance to 
psychological causal explanations, the more optimistic views of prognosis and treatments, and the lower level of 
prejudices found in this group might reflect their attitudes towards people with depression. Moreover, NSD GPs 
recommended less frequently the psychiatrist, and did not recommended any other professional more frequently. This 
situation may lead to an underestimation of clients’ needs for mental health care and to a delay in the provision of 
appropriate treatments. Therefore, it is possible that GPs who were not able to identify schizophrenia in the description 
are in need of more training or education on mental health problems. We did not find significant differences among the 
three groups in beliefs about whether PWS are capable of reporting health problems to doctors, or have insights into 
their own conditions. However, only 24.3% of the total sample viewed these persons as reliable in reporting their 
physical problems and 19.6% in reporting their mental health problems. GPs’ skepticism toward reliability and insight 
of people with psychosis may discourage clients themselves from help-seeking, with further negative effects on their 
health. 
Although 81.4% of participants stated they had clients with the mental health problem, only 31.3% to 43.1% 
recommended the GP among the treating professionals. These results suggest that GPs are not particularly willing to 
take care of persons with severe mental health problems, and/or that they feel insufficiently skilled to work with these 
clients.  
The results of this study highlight that there may be a need to provide some GPs with training on clinical features 
of schizophrenia and education about stigma and its effects on health (Ucok et al., 2006). Based on the findings of this 
study, we are planning educational initiatives to provide GPs with information on the experience of psychosis, actual 
rates of recovery, risks of dangerous behaviours, and effectiveness of both drug and psychological treatments for this 
problem and to sensitise them to stigma. These initiatives are partly based on testimonies of individuals who have 
recovered or are living successfully with symptoms of psychosis, which have been found to be effective for improving 
attitudes toward PWS among trainee medical doctors and psychologists (Magliano et al., 2014). Moreover, in order to 
support a more optimistic and evidence-based view of prognosis among health professionals, efforts are needed to make 
available integrated bio-psycho-social interventions in mental health services for all PWS who may benefit. We hope 
that such strategies will help to improve knowledge of GPs about psychosis, and increase GPs’ attitudes towards PWS, 
and thereby increase the probability that these persons will receive the same attention for their health problems, and 
same quality of primary care, as other citizens.  
 
Strengths and limitations of the study 
This is the first study carried out in Italy that has specifically explored GPs views of schizophrenia and whether 
they varied in relation to GPs’ ability of making this diagnosis and diagnostic label per se. Among the strengths of the 
study are the inclusion of a relatively large and randomly selected sample, the use of control groups, the face-to-face 
data collection, and the high participation rate (90%). The use of a self-reported questionnaire whose psychometric 
properties have been found to be satisfactory is an additional strength, also facilitating its replication in other health care 
contexts. The study also, however, has a number of limitations suggesting caution in the interpretation of its results: a) a 
mean age of 58, so the results may be not representative of younger GPs; b) the inclusion of GPs from only one 
metropolitan area located in southern Italy, a geographical area where healthcare resources are poorer (Magliano et al., 
2002) and public prejudices towards PWS are higher than in other areas of the country (Magliano et al., 2004b); c) the 
focus only on beliefs regarding schizophrenia, one of the most stigmatised of mental health problems worldwide 
(Pescosolido,  Medina, Martin, & Long, 2013) so its findings cannot be generalised to other mental disorders whose 
familiarity and acceptance by health professionals is higher (Lawrie et al., 1998; Schomerus, Matschinger, & 
Angermeyer, 2013); d) the survey investigated only the opinions of GPs, and may not reflect GPs’ actual behaviours 
with PWS in clinical practice; e) the cross-sectional design of the study does not permit inferences regarding the effects 
of  labelling on GPs’ views over time.  
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Appendix (clinical description provided only to 50% of selected GPs, those who were asked to complete the 
questionnaire in reference to “people with a condition like that reported in the clinical description” and to make a 
diagnosis) 
   
Some people sometimes seem unable to distinguish between things that really happen and are experienced by other 
people, and things that happen only in their mind. Sometimes, these people believe or say things that seem bizarre or 
absurd to other people, or hear voices, smell things, or see images that other people do not. Sometimes, these people 
may have difficulty expressing their feelings or behaving appropriately (for instance, they may cry in response to a 
positive event, or may appear happy following an unpleasant one), or they may remain shut up in their house for a long 
time, or talk very little or not at all. They behave as if they lived in a world of their own, apparently without interest in 
anything or anybody. Sometimes they may have muddled thoughts, may invent odd or incomprehensible words, may 
lose the thread of the speech, or they may jump from one issue to another with no apparent reason. 
 Table 1.  GP’ beliefs about the factors involved in the development of schizophrenia in the three groups and in 
total sample (N=387). 
 GP groups  
Causes NSD (N=65) ASD (N=127) PSD (N=195) Total sample (N=387) 
 N % N % N % N % 
Heredity* 27 41.5 112 88.2 163 83.6 302 78.0 
Chemical imbalance 26 40.0 67 52.8 102 52.3 195 50.4 
Use of street drugs 28 43.1 75 59.1 95 48.7 198 51.2 
Psychological violence 31 47.7 53 41.7 84 43.1 168 43.4 
Use of alcohol 30 46.2 53 41.7 70 35.9 153 39.5 
Traumatic events 31 47.7 50 39.4 67 34.4 148 38.2 
Stress* 46 70.8 30 23.6 60 30.8 136 35.1 
Physical violence 25 38.5 28 22.0 54 27.7 107 27.6 
Sexual abuses 25 38.5 30 23.6 54 27.7 109 28.2 
Family conflicts* 36 55.4 27 21.3 52 26.7 115 29.7 
Poor parenthood 17 26.2 29 22.8 47 24.1 93 24.0 
Bereavements* 33 50.8 25 19.7 32 16.4 90 23.3 
Physical illness* 18 27.7 11 8.7 14 7.2 43 11.1 
Work difficulties* 34 52.3 17 13.4 30 15.4 81 20.9 
Disillusionment in love* 26 40.0 17 13.4 28 14.4 71 18.7 
Illness in pregnancy 14 21.5 17 13.4 26 13.3 57 14.7 
NSD:  No Schizophrenia Diagnosis - those in the group that were asked to make a diagnosis but did not respond with “schizophrenia”; ASD: Active 
Schizophrenia Diagnosis- those in the group that were asked to make a diagnosis and responded with “schizophrenia” PSD: Passive Schizophrenia 




Table 2. GPs views of schizophrenia in total sample (N=387). 
    
 GPs answers  
OQ items 
“Not true” “Partially true” “Completely 
true” 
 N % N % N 
% 
 
§ can recover 42 11.5 226 61.9 97 26.6 
Drugs are useful for § 6 1.6 133 34.5 247 64.0 
Psychological interventions are useful  for § 13 3.4 150 39.3 219 57.3 
§ must take drugs over the life 66 18.1 160 44.0 138 37.9 
If stop taking drugs, § become dangerous 94 26.0 190 52.6 77 21.3 
If stop taking drugs, § become unwell again 37 9.9 188 50.4 148 39.7 
§ do not realize that they are ill 42 11.2 211 56.1 123 32.7 
§ do not realize when they become unwell 47 12.4 178 47.1 153 40.5 
§ are unpredictable 43 11.5 186 49.9 144 38.6 
§ are kept at distance by the others 55 14.6 179 47.6 142 37.8 
People do not know how to behave with § 19 5.0 151 39.7 210 55.3 
People do not understand the difficulties experienced by § 10 2.6 132 34.6 240 62.8 
People are frightened by § 23 6.1 116 30.5 241 63.4 
§are dangerous to themselves 44 11.8 225 60.2 105 28.1 
§are dangerous to others 47 12.7 239 63.4 91 24.1 
In a non-psychiatric hospital ward, §create discomfort to other 
patients 
76 20.9 192 52.9 95 26.2 
In a non-psychiatric hospital ward, §should be separated from 
other patients 
173 49.0 123 34.0 57 16.1 
When § are admitted to non-psychiatric wards, psychiatric advice 
should always be requested 
20 5.2 87 22.8 274 71.9 
In non-psychiatric hospital wards, §should be supervised  (for 
instance, by additional  nurse) 
104 29.5 149 42.2 100 28.3 
§ are reliable in  referring their mental problems to medical 
doctors 
68 18.3 231 62.1 73 19.6 
§ are reliable in  referring their physical problems to medical 
doctors 
56 14.9 228 60.8 91 24.3 
It is difficult for § to have a love relationship 83 24.6 162 48.1 92 27.3 
It is difficult for § to get married or to live together with a partner 64 201 172 50.0 103 29.9 
 
§ =  Persons with a condition like that reported in the clinical description or PWS 
 
 
  Table 3. Confirmatory Factor Analysis on the QO section c items (N=387). 
 
QO section c items Factor loadings 
 1 2 3 4 5 6 7 8 9 10 
§ can recover 0.58          
Drugs are useful for §  0.52         
Psychological interventions are useful  for §   0.56        
§ must take drugs over the life    0.44       
If stop taking drugs, § become dangerous    0.53       
If stop taking drugs, § become unwell again    0.46       
§ do not realize that they are ill     0.41      
§ do not realize when they become unwell     0.49      
§ are unpredictable      0.28     
§ are kept at distance by the others      0.38     
People do not know how to behave with §      0.46     
People do not understand the difficulties 
experienced by § 
     0.38     
People are frightened by §      0.41     
§are dangerous to themselves       0.47    
§are dangerous to others       0.54    
In a non-psychiatric hospital ward, §create 
discomfort to other patients 
       0.57   
In a non-psychiatric hospital ward, §should 
be separated from other patients 
       0.50   
When § are admitted to non-psychiatric 
wards, psychiatric advice should always be 
requested 
       0.23   
In non-psychiatric hospital wards, §should 
be supervised  (for instance, by additional  
nurse) 
       0.42   
§ are reliable in  referring their mental 
problems to medical doctors 
        0.54  
§ are reliable in  referring their physical 
problems to medical doctors 
        0.42  
It is difficult for § to have a love relationship          0.57 
It is difficult for § to get married or to live 
together with a partner 
         0.54 
Cronbach’s alpha value - - - 0.76 0.66 0.75 0.84 0.74 0.77 0.81 
 
§ persons with  a condition like that reported in the description or PWS; Factor 1: possibility to recover;  2: usefulness of pharmacological treatments; 3: 
usefulness of psychological therapies; 4:  need of long-term pharmacological therapies; 5:  insight of PWS; 6:  perception of social distance from PWS; 7: 
perception of dangerousness; 8: treatments of PWS  in non-psychiatric hospital wards; 9: reliability of PWS in reporting their health condition to medical 
doctors;10: difficulties of PWS in having romantic relationships. Maximum likelihood estimation of the covariances. Fit indexes: χ2 =320.35, df 188, N= 
387, p<0.05; NNFI=0.95; CFI=0.97; RMSEA=0.04(0.03; 0.05); SRMR=0.04. All factor loadings are statistically significant at p<0.001.  The correlations 
among the ten factors were all significant for p < .05, except those between factor 1 with 2, 5,6 and 9; between factor 2 and 5, 7, 9, and 10; between factor 
3 and 5, 6, 7, 8, 9, 10; between factor 5 and 10 (standardized solution). 
 
 Table 4. Comparisons of GPs views of schizophrenia in the three groups. 
  GPs groups   
 NSD ASD PSD MANOVA 
OQ factors Mean SE Mean SE Mean SE F (1,314)a 
1 Possibility to recover in § 2.47a 0.08 2.08b 0.06 2.11b 0.05 9.7* 
2 Usefulness of pharmacological treatments  2.32b 0.07 2.66a 0.05 2.68 a 0.04 11.5* 
3 Usefulness of psychological therapies 2.61 0.07 2.52 0.06 2.50 0.05 0.8 
4 Needs of long-term pharmacological 
therapies 
1.77b 0.07 2.16a 0.05 2.29a 0.04 18.8* 
5 Insight of § 2.29 0.08 2.32 0.06 2.18 0.05 2.1 
6 Perception of social distance from § 2.21b 0.06 2.45a 0.04 2.49a 0.03 8.5* 
7 Perception of dangerousness of § 1.88b 0.07 2.22a 0.05 2.18a 0.04 7.8* 
8 Treatments of § in non-psychiatric 
hospital wards 
1.88b 0.07 2.10a 0.05 2.17a 0.04 6.7* 
9 Reliability of § in reporting health 
problems to medical doctors 
2.21 0.07 2.09 0.05 2.04 0.04 2.0 
10 Difficulties of § in having romantic 
relationships 
1.95 0.09 2.09 0.06 2.07 0.05 0.9 
 
NSD:  No Schizophrenia Diagnosis - those in the group that were asked to make a diagnosis but did not respond with “schizophrenia”; ASD: Active 
Schizophrenia Diagnosis - those in the group that were asked to make a diagnosis and responded with “schizophrenia”;  PSD: Passive Schizophrenia 
Diagnosis - those in the group who were given the diagnosis; Multivariate Analysis of Variance (MANOVA): dependent variables =  mean scores of 
1- 10 QO factors;  independent variables =  NSD, ASD and PSD. MANOVA Wilks’λ = .76, F (20,604) = 4.42, p< 0.0001;   a, b univariate post-hoc 
analysis; estimated marginal means; adjustment for multiple comparisons: Bonferroni,  a>b; * p<0.001; § persons with  a condition like that reported 
in the description or PWS.  
 
 
 
